In a latest study, we noted the identification and the characterization of a completely new atypical opioid receptor with exceptional adverse regulatory properties in the direction of opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also https://aarona790mxk7.blogdiloz.com/profile